secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2025-10-15T23:59:59+00:00
Accession:  0001493152-25-018123
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs enters into ATM equity offering facility with WestPark Capital
----------------------------------------------------------------------------

- ProPhase Labs entered an At-the-Market Sales Agreement with WestPark Capital on Oct 9, 2025, to sell common stock from time to time.
- Agent receives 3.0% commission on gross proceeds; company reimburses certain expenses.
- Sales made under existing effective S-3 registration statement (No. 333-283182) declared effective Nov 20, 2024.
- Company is not obligated to sell any shares; may suspend or terminate agreement at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000149315225018123/0001493152-25-018123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000149315225018123/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-018123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer